Imaging in head and neck oncology
- PMID: 15062359
- DOI: 10.1016/S1055-3207(03)00124-8
Imaging in head and neck oncology
Abstract
Evaluation of head and neck cancer with imaging is a topic that is far more extensive than can be covered in this article. The main reason for head and neck imaging is to evaluate the true extent of disease to best determine surgical and therapeutic options. This process includes evaluation of the size, location, and extent of tumor infiltration into surrounding vascular and visceral structures. Important anatomic variants must be pointed out so the surgeon can avoid potential intraoperative complications. These variant scan be evaluated with the appropriate multiplanar and three-dimensional images to provide as much information as possible to the surgeon preoperatively. Second, nodal staging should be assessed in an effort to increase the number of abnormal nodes detected by physical examination and, more important, to precisely define their location by a standard classification system that can be understood and consistently applied by the radiologist, surgeon, radiation oncologist, and pathologist. Although secondary to the previously described tasks, imaging frequently enables a limitation of the diagnostic and histologic possibilities based on lesion location and signal-attenuation characteristics, which may lead the clinical investigation along a different path. saving the patient unnecessary risk and shortening the time to diagnosis and ultimate treatment. This article has attempted to detail the current state of the controversy between CT, MRI, and other modalities, and has emphasized the constant evolution of this controversy because of the evolving imaging technology. Although CT and MRI are both well suited to evaluation of the deep spaces and submucosal spaces of the head and neck, each has some limitations.MRI has the advantages of higher soft tissue contrast resolution, the lack of iodine-based contrast agents, and high sensitivity for perineural and intracranial disease. The disadvantages of MRI include lower patient tolerance, contraindications in pacemakers and certain other implanted metallic devices, and artifacts related to multiple causes, not the least of which is motion. CT is fast, well tolerated, and readily available but has lower contrast resolution and requires iodinated contrast and ionizing radiation. The current authors' practice is heavily centered on CT for initial evaluation, preoperative planning, biopsy targeting, and postoperative follow-up. They reserve MRI for tumors that are suspicious for perineural,cartilaginous, or bony invasion on CT, or for tumors such as adenoid cystic carcinoma that are highly likely to spread by way of these routes. For patients who have head and neck cancer, a radiologist who is educated in the treatment options, patterns of tumor growth, and important surgical landmarks, and who has a well-established pattern of communication with the head and neck clinical services, including surgery, radiation oncology,and pathology, is key in providing accurate and useful image interpretation.
Similar articles
-
The sensitivity and specificity of high-resolution imaging in evaluating perineural spread of adenoid cystic carcinoma to the skull base.Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):541-5. doi: 10.1001/archotol.133.6.541. Arch Otolaryngol Head Neck Surg. 2007. PMID: 17576903
-
[Results of pretherapeutic lymph node diagnosis in head and neck tumors. Clinical value of 18-FDG positron emission tomography (PET)].Laryngorhinootologie. 2000 Apr;79(4):201-6. doi: 10.1055/s-2000-8795. Laryngorhinootologie. 2000. PMID: 10838683 German.
-
[Current oncologic concepts and emerging techniques for imaging of head and neck squamous cell cancer].Laryngorhinootologie. 2012 Mar;91 Suppl 1:S27-47. doi: 10.1055/s-0031-1297259. Epub 2012 Mar 28. Laryngorhinootologie. 2012. PMID: 22456918 Review. German.
-
Prospective comparison of 18F-FDG PET with conventional imaging modalities (MRI, CT, and 67Ga scintigraphy) in assessment of combined intraarterial chemotherapy and radiotherapy for head and neck carcinoma.J Nucl Med. 2003 Feb;44(2):198-206. J Nucl Med. 2003. PMID: 12571209 Clinical Trial.
-
[Role and responsibility of multimodal imaging in head and neck cancer].Magy Onkol. 2013 Sep;57(3):182-202. Epub 2013 Sep 20. Magy Onkol. 2013. PMID: 24107825 Review. Hungarian.
Cited by
-
Advances and Innovations in Ablative Head and Neck Oncologic Surgery Using Mixed Reality Technologies in Personalized Medicine.J Clin Med. 2022 Aug 16;11(16):4767. doi: 10.3390/jcm11164767. J Clin Med. 2022. PMID: 36013006 Free PMC article.
-
Additive Manufacturing of Resected Oral and Oropharyngeal Tissue: A Pilot Study.Int J Environ Res Public Health. 2021 Jan 21;18(3):911. doi: 10.3390/ijerph18030911. Int J Environ Res Public Health. 2021. PMID: 33494422 Free PMC article.
-
Prognostic value of MRI-derived masticator space involvement in IMRT-treated nasopharyngeal carcinoma patients.Radiat Oncol. 2015 Sep 25;10:204. doi: 10.1186/s13014-015-0513-6. Radiat Oncol. 2015. PMID: 26407897 Free PMC article.
-
Differentiation of benign and malignant lesions of the tongue by using diffusion-weighted MRI at 3.0 T.Dentomaxillofac Radiol. 2015;44(7):20140325. doi: 10.1259/dmfr.20140325. Epub 2015 Mar 31. Dentomaxillofac Radiol. 2015. PMID: 25823772 Free PMC article.
-
Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance.Transl Oncol. 2014 Dec;7(6):780-7. doi: 10.1016/j.tranon.2014.10.003. Transl Oncol. 2014. PMID: 25500088 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical